0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Glioma - Immunotherapeutic Approaches (Paperback, Softcover reprint of the original 1st ed. 2012) Loot Price: R3,258
Discovery Miles 32 580
Glioma - Immunotherapeutic Approaches (Paperback, Softcover reprint of the original 1st ed. 2012): Ryuya Yamanaka

Glioma - Immunotherapeutic Approaches (Paperback, Softcover reprint of the original 1st ed. 2012)

Ryuya Yamanaka

Series: Advances in Experimental Medicine and Biology, 746

 (sign in to rate)
Loot Price R3,258 Discovery Miles 32 580 | Repayment Terms: R305 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Treatment of glioma is currently one of the most challenging problems in oncology, as well as in neurosurgery. Despite major advances in our understanding of the pathomechanism, diagnosis by imaging and the availability of powerful therapeutic tools, the life expectancy of patients with glioblastoma has only been slightly prolonged and a cure remains elusive. None of the currently available surgical tools, including operative microscopes, lasers and image-guided surgery, can enable the detection and removal of all of the tumor tissue. In recent years, however, the landscape has been changing immeasurably, and molecular studies over the past two decades have identified a variety of genetic aberrations that are specifically associated with individual types of gliomas. In addition, certain molecular abnormalities have been linked to therapy responses, thereby establishing clinical biomarkers and molecular targets, and the use of novel agents is being investigated. These agents have been specifically engineered to exert specific cytotoxicity against gliomas, either on their own as single agents or in combination with other modalities. Moreover, there has been an enormous surge of interest in the area of immunology and immunotherapy, which has been facilitated by our understanding of the molecular basis of gliomas. Although several kinds of immunotherapeutic trials have been undertaken, we still await a great breakthrough in terms of clinical efficacy to prolong the survival time of glioma patients.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 746
Release date: August 2016
First published: 2012
Editors: Ryuya Yamanaka
Dimensions: 254 x 178mm (L x W)
Format: Paperback
Pages: 232
Edition: Softcover reprint of the original 1st ed. 2012
ISBN-13: 978-1-4939-4439-2
Categories: Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 1-4939-4439-8
Barcode: 9781493944392

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners